Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database
BackgroundWith the widespread use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in managing diabetes and obesity, the occurrence of GLP-1 RA-induced cholecystitis and cholelithiasis has raised increasing concern among healthcare professionals.MethodsThis study extracted adverse event repo...
Saved in:
Main Authors: | Chao Tao, Yinhui Zhang, Tenggang Wan, Wenting Zhao, Jing Chen, Ke Wang, Liuxuan Yang, Guojun Wang, Qian Ding, Jinlu Shang, Meiling Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1557691/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors of acute and chronic cholecystitis and cholelithiasis
by: V. A. Lazarenko, et al.
Published: (2016-12-01) -
Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database
by: Huiling Zhang, et al.
Published: (2025-07-01) -
Preoperative method of assessment of gallbladder lesion in acute cholecystitis
by: A. A. Yashnov, et al.
Published: (2022-07-01) -
Assessment of drug-related migraine in a real-world large-scale database
by: Fan Wu, et al.
Published: (2025-07-01) -
Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system
by: Qian Yu, et al.
Published: (2025-08-01)